16-84191267-A-G
Variant summary
Our verdict is Benign. Variant got -10 ACMG points: 0P and 10B. BP4_StrongBP6_ModerateBS2
The ENST00000315906.10(ADAD2):āc.37A>Gā(p.Ser13Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000199 in 1,600,680 control chromosomes in the GnomAD database, including 3 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā ).
Frequency
Consequence
ENST00000315906.10 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -10 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ADAD2 | NM_001145400.2 | c.37A>G | p.Ser13Gly | missense_variant | 1/10 | ENST00000315906.10 | NP_001138872.1 | |
ADAD2 | NM_139174.4 | c.37A>G | p.Ser13Gly | missense_variant | 1/11 | NP_631913.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ADAD2 | ENST00000315906.10 | c.37A>G | p.Ser13Gly | missense_variant | 1/10 | 1 | NM_001145400.2 | ENSP00000325153 | P1 | |
ADAD2 | ENST00000268624.7 | c.37A>G | p.Ser13Gly | missense_variant | 1/11 | 2 | ENSP00000268624 | |||
ADAD2 | ENST00000567413.1 | n.77A>G | non_coding_transcript_exon_variant | 1/2 | 4 |
Frequencies
GnomAD3 genomes AF: 0.000210 AC: 32AN: 152218Hom.: 0 Cov.: 35
GnomAD3 exomes AF: 0.000264 AC: 58AN: 219696Hom.: 0 AF XY: 0.000343 AC XY: 42AN XY: 122534
GnomAD4 exome AF: 0.000198 AC: 287AN: 1448348Hom.: 3 Cov.: 88 AF XY: 0.000222 AC XY: 160AN XY: 719604
GnomAD4 genome AF: 0.000210 AC: 32AN: 152332Hom.: 0 Cov.: 35 AF XY: 0.000228 AC XY: 17AN XY: 74484
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 16, 2024 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at